Showing results (1191-1200 of 1,219) with videos related to

Sort By:
Pageof 122
The New England Journal of Medicine|February 19, 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.
Blood|October 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 Cohort 3Tom van Meerten, Marie José Kersten, Gloria Iacoboni, et al.
Journal of the American Veterinary Medical Association|November 16, 2024
Identification of raccoon rabies virus variant in a stray kitten: the role of veterinary practitioners in detection and reporting of a non-native zoonotic pathogen-Nebraska, 2023Ann Carpenter, Emma R Price, Sydney R Stein, et al.
Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.
Neuro-Oncology Advances|April 28, 2023
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experienceTimothy A Gregory, Maximilian Mastall, Heather Lin, et al.
BMC Medicine|October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation setJason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Cancer Immunology Research|October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal ResponsesJames W Welsh, Chad Tang, Patricia de Groot, et al.
JCI Insight|December 7, 2018
A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDSLaura E Fredenburgh, Mark A Perrella, Diana Barragan-Bradford, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
JAMA|February 4, 2015
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trialJohn B Holcomb, Barbara C Tilley, Sarah Baraniuk, et al.
Pageof 122